Studies Identify Blood Tests That Could Reduce Need for Liver Biopsies
New findings show how blood-based biomarkers could improve detection of advanced liver disease and guide decisions about further testing.
Read MorePosted by CLP Edit Staff | Oct 30, 2026 | Diabetes & Metabolic Diseases |
New findings show how blood-based biomarkers could improve detection of advanced liver disease and guide decisions about further testing.
Read MorePosted by CLP Edit Staff | Oct 15, 2026 | Cancer, Cytology, Womens Health |
The DNA-based test showed 96.8% specificity in cervical samples and could help physicians determine which patients need further testing for endometrial cancer.
Read MorePosted by CLP Edit Staff | Sep 21, 2026 | Company News, Diabetes & Metabolic Diseases |
Siemens Healthineers and Novo announced a collaboration to expand clinical access to non-invasive blood tests, including the ELF test, for earlier detection of MASLD and MASH.
Read MorePosted by Alyx Arnett | Sep 1, 2026 | Coagulation Testing, Sponsored |
From clot formation to functional and antigen testing, fibrinogen measurement helps laboratories evaluate bleeding disorders, monitor critical illness, and support patient care.
Read MorePosted by CLP Edit Staff | Aug 4, 2026 | Cancer, Molecular Diagnostics |
Researchers at Johns Hopkins validated an AI-powered blood test that accurately detects liver cancer in diverse populations, using the DELFI platform to analyze cell-free DNA fragments.
Read More